Advanced Search

Review Product Marketing Authorisation For Human Use «Prazepam Eg».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Prazepam EG».

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
Retrieved January 14, 2015 V&A # 32/2015 Procedure determines the EU _ #: BE/H/0143/001-011 003/II/type II variation: b. 1. z) is authorized the following variation: updating the ASMF 01.01/2010-ASMF ed. (March 2010) to version Ed. 02.00/2014-ASMF (January 2014); the update affects only the Applicant part while the Restricted part remains unchanged.
With respect to medicinal product: PRAZEPAM EG and at authorised pack sizes the placing in Italy following the mutual recognition procedure.
Mah: EG S.P.A.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1 subparagraph 5 of April 14, 2014 # 371 of AIFA determines published in Official Gazette No 101 of May 3, 2014.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.